Anteilseigner
TCG Crossover Management LLC (9,90 %) Great Point Partners LLC (6,88 %) StemPoint Capital LP (6,84 %) The Vanguard Group, Inc. (6,60 %) Commodore Capital LP (5,83 %) Nantahala Capital Management LLC (5,62 %) Sphera Funds Management Ltd. (2,99 %) Citadel Advisors LLC (2,75 %) Venrock Associates (2,55 %) NEA Management Co. LLC (2,01 %) Armistice Capital LLC (1,35 %) BlackRock Fund Advisors (1,29 %) Geode Capital Management LLC (1,03 %) Susquehanna Financial Group LLLP (0,98 %) Goldman Sachs & Co. LLC (Private Banking) (0,61 %) BML Capital Management LLC (0,56 %) Two Sigma Investments LP (0,53 %) Renaissance Technologies LLC (0,41 %) Adar1 Capital Management LLC (0,33 %)
Kontakt
Vistagen Therapeutics Inc.